VEXAS Syndome

Clinical trial pipeline · Data from ClinicalTrials.gov

See which VEXAS Syndome trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingPhase 2

NCT07098936

Momelotinib in VEXAS Syndrome

Multicenter, phase II trial with safety run-in to evaluate the efficacy and safety of momelotinib in patients with VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinf…

France57 participantsStarted 2025-11-25

Treatment: Momelotinib treatment

RecruitingNot Applicable

NCT06004349

Autoimmune and Autoinflammatory Genetics Study

This is an exploratory natural history protocol that will enroll patients with known genetic diseases, such as VEXAS syndrome, or as yet undiagnosed disorders o…

United States1,500 participantsStarted 2022-04-15

VEXAS Syndome

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Momelotinib in VEXAS Syndrome

Autoimmune and Autoinflammatory Genetics Study

All recent trials (2 shown)

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Momelotinib in VEXAS Syndrome

Autoimmune and Autoinflammatory Genetics Study

All recent trials (2 shown)